Literature DB >> 11734625

Doppel-induced cerebellar degeneration in transgenic mice.

R C Moore1, P Mastrangelo, E Bouzamondo, C Heinrich, G Legname, S B Prusiner, L Hood, D Westaway, S J DeArmond, P Tremblay.   

Abstract

Doppel (Dpl) is a paralog of the mammalian prion protein (PrP); it is abundant in testes but expressed at low levels in the adult central nervous system. In two Prnp-deficient (Prnp(0/0)) mouse lines (Ngsk and Rcm0), Dpl overexpression correlated with ataxia and death of cerebellar neurons. To determine whether Dpl overexpression, rather than the dysregulation of genes neighboring the Prn gene complex, was responsible for the ataxic syndrome, we placed the mouse Dpl coding sequence under the control of the Prnp promoter and produced transgenic (Tg) mice on the Prnp(0/0)-ZrchI background (hereafter referred to as ZrchI). ZrchI mice exhibit neither Dpl overexpression nor cerebellar degeneration. In contrast, Tg(Dpl)ZrchI mice showed cerebellar granule and Purkinje cell loss; the age of onset of ataxia was inversely proportional to the levels of Dpl protein. Crosses of Tg mice overexpressing wild-type PrP with two lines of Tg(Dpl)ZrchI mice resulted in a phenotypic rescue of the ataxic syndrome, while Dpl overexpression was unchanged. Restoration of PrP expression also rendered the Tg(Dpl) mice susceptible to prion infection, with incubation times indistinguishable from non-Tg controls. Whereas the rescue of Dpl-induced neurotoxicity by coexpression of PrP argues for an interaction between the PrP and Dpl proteins in vivo, the unaltered incubation times in Tg mice overexpressing Dpl in the central nervous system suggest that Dpl is unlikely to be involved in prion formation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11734625      PMCID: PMC65022          DOI: 10.1073/pnas.251550798

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Mimicking dominant negative inhibition of prion replication through structure-based drug design.

Authors:  V Perrier; A C Wallace; K Kaneko; J Safar; S B Prusiner; F E Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

2.  A C-terminal-truncated PrP isoform is present in mature sperm.

Authors:  Y Shaked; H Rosenmann; G Talmor; R Gabizon
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

Review 3.  Know your neighbors: three phenotypes in null mutants of the myogenic bHLH gene MRF4.

Authors:  E N Olson; H H Arnold; P W Rigby; B J Wold
Journal:  Cell       Date:  1996-04-05       Impact factor: 41.582

Review 4.  [Physiopathology and molecular diagnosis for prion diseases].

Authors:  S Katamine
Journal:  Rinsho Byori       Date:  2000-05

5.  Neuronal apoptosis in HIV infection in adults.

Authors:  H Adle-Biassette; Y Levy; M Colombel; F Poron; S Natchev; C Keohane; F Gray
Journal:  Neuropathol Appl Neurobiol       Date:  1995-06       Impact factor: 8.090

6.  In vivo transfer of GPI-linked complement restriction factors from erythrocytes to the endothelium.

Authors:  D L Kooyman; G W Byrne; S McClellan; D Nielsen; M Tone; H Waldmann; T M Coffman; K R McCurry; J L Platt; J S Logan
Journal:  Science       Date:  1995-07-07       Impact factor: 47.728

7.  Chimeric prion protein expression in cultured cells and transgenic mice.

Authors:  M R Scott; R Köhler; D Foster; S B Prusiner
Journal:  Protein Sci       Date:  1992-08       Impact factor: 6.725

8.  129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal.

Authors:  J C Manson; A R Clarke; M L Hooper; L Aitchison; I McConnell; J Hope
Journal:  Mol Neurobiol       Date:  1994 Apr-Jun       Impact factor: 5.590

9.  Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins.

Authors:  D Westaway; S J DeArmond; J Cayetano-Canlas; D Groth; D Foster; S L Yang; M Torchia; G A Carlson; S B Prusiner
Journal:  Cell       Date:  1994-01-14       Impact factor: 41.582

10.  Prion isolate specified allotypic interactions between the cellular and scrapie prion proteins in congenic and transgenic mice.

Authors:  G A Carlson; C Ebeling; S L Yang; G Telling; M Torchia; D Groth; D Westaway; S J DeArmond; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

View more
  53 in total

Review 1.  Transgenesis applied to transmissible spongiform encephalopathies.

Authors:  Jean-Luc Vilotte; Hubert Laude
Journal:  Transgenic Res       Date:  2002-12       Impact factor: 2.788

2.  Expression of truncated PrP targeted to Purkinje cells of PrP knockout mice causes Purkinje cell death and ataxia.

Authors:  Eckhard Flechsig; Ivan Hegyi; Rainer Leimeroth; Armando Zuniga; Daniela Rossi; Antonio Cozzio; Petra Schwarz; Thomas Rülicke; Jürgen Götz; Adriano Aguzzi; Charles Weissmann
Journal:  EMBO J       Date:  2003-06-16       Impact factor: 11.598

3.  Gene expression profile following stable expression of the cellular prion protein.

Authors:  Jun-ichi Satoh; Takashi Yamamura
Journal:  Cell Mol Neurobiol       Date:  2004-12       Impact factor: 5.046

4.  Altered neuron excitability and synaptic plasticity in the cerebellar granular layer of juvenile prion protein knock-out mice with impaired motor control.

Authors:  Francesca Prestori; Paola Rossi; Bertrand Bearzatto; Jeanne Lainé; Daniela Necchi; Shyam Diwakar; Serge N Schiffmann; Herbert Axelrad; Egidio D'Angelo
Journal:  J Neurosci       Date:  2008-07-09       Impact factor: 6.167

5.  Towards authentic transgenic mouse models of heritable PrP prion diseases.

Authors:  Joel C Watts; Kurt Giles; Matthew E C Bourkas; Smita Patel; Abby Oehler; Marta Gavidia; Sumita Bhardwaj; Joanne Lee; Stanley B Prusiner
Journal:  Acta Neuropathol       Date:  2016-06-28       Impact factor: 17.088

6.  A highly toxic cellular prion protein induces a novel, nonapoptotic form of neuronal death.

Authors:  Heather M Christensen; Krikor Dikranian; Aimin Li; Kathleen C Baysac; Ken C Walls; John W Olney; Kevin A Roth; David A Harris
Journal:  Am J Pathol       Date:  2010-05-14       Impact factor: 4.307

Review 7.  Redox control of prion and disease pathogenesis.

Authors:  Neena Singh; Ajay Singh; Dola Das; Maradumane L Mohan
Journal:  Antioxid Redox Signal       Date:  2010-06-01       Impact factor: 8.401

8.  Targeting prion-like protein doppel selectively suppresses tumor angiogenesis.

Authors:  Taslim A Al-Hilal; Seung Woo Chung; Jeong Uk Choi; Farzana Alam; Jooho Park; Seong Who Kim; Sang Yoon Kim; Fakhrul Ahsan; In-San Kim; Youngro Byun
Journal:  J Clin Invest       Date:  2016-03-07       Impact factor: 14.808

9.  Dominant-negative effects of the N-terminal half of prion protein on neurotoxicity of prion protein-like protein/doppel in mice.

Authors:  Daisuke Yoshikawa; Naohiro Yamaguchi; Daisuke Ishibashi; Hitoki Yamanaka; Nobuhiko Okimura; Yoshitaka Yamaguchi; Tsuyoshi Mori; Hironori Miyata; Kazuto Shigematsu; Shigeru Katamine; Suehiro Sakaguchi
Journal:  J Biol Chem       Date:  2008-06-18       Impact factor: 5.157

10.  Shadoo (Sprn) and prion disease incubation time in mice.

Authors:  Sarah E Lloyd; Julia Grizenkova; Hirva Pota; John Collinge
Journal:  Mamm Genome       Date:  2009-06-10       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.